| Product NDC: | 0409-4093 |
| Proprietary Name: | CHROMIUM |
| Non Proprietary Name: | CHROMIC CHLORIDE |
| Active Ingredient(s): | 4 ug/mL & nbsp; CHROMIC CHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-4093 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018961 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110811 |
| Package NDC: | 0409-4093-01 |
| Package Description: | 1 TRAY in 1 CASE (0409-4093-01) > 25 VIAL, PLASTIC in 1 TRAY > 10 mL in 1 VIAL, PLASTIC |
| NDC Code | 0409-4093-01 |
| Proprietary Name | CHROMIUM |
| Package Description | 1 TRAY in 1 CASE (0409-4093-01) > 25 VIAL, PLASTIC in 1 TRAY > 10 mL in 1 VIAL, PLASTIC |
| Product NDC | 0409-4093 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CHROMIC CHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110811 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | CHROMIC CHLORIDE |
| Strength Number | 4 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient] |